Dossier
Cui Cui
Coverage of Cui Cui in the Nexus archive.
- Chinese pharmaceutical firms’ cost advantages trump Pentagon blacklist: analysts
The Pentagon added Chinese pharmaceutical contractor WuXi AppTec to an entity list linked to China’s military, but analysts say the move will not deter multinational drug makers from collaborating with Chinese firms due to cost advantages. Jefferies' healthcare research head Cui Cui noted that cost efficiency in China's pharmaceutical manufacturing remains a key factor for multinational companies.
- Chinese pharmaceutical firms’ cost advantages trump Pentagon blacklist: analysts
The Pentagon added Chinese pharmaceutical contractor WuXi AppTec to a list of entities it alleges are linked to the country’s military, but analysts say the blacklisting will not stop multinational drug makers from collaborating with China’s biopharmaceutical firms due to cost advantages.